OPRK1 and Alzheimer disease: Because KOR agonism and MOR antagonism both appear to exert potent anti-pruritic as well as anti-inflammatory effects, one might speculate that therapeutic agents combining these approaches (e.g., Nalbuphine) may be especially potent in improving AD (Figure 5).